cancer/fda doco, page-2

caveman,

Let's hope we won't have to walk exactly the same path as prostate cancer sufferers did in protest against the FDA decision for the approval of Dendreon's Provenge. How many hundreds of thousands of US men died as a direct result of this FDA scandal?

2007 rally outside the FDA Headquarters

When considering the CVac has already clearly shown better response rates for each patient subjected to the least amount of prior chemo/radio treatments, it must be fair to question why CVac can't be made available as a first-line therapy treatment for Ovarian cancer?

The purpose of this CVac phasellb trial is to determine the safety and efficacy of a dendritic cell vaccine compared with "Standard of Care" in ovarian cancer patients who are in remission after first or second-line therapy...?

I fail to understand the logic in this process. Firstly, imo it doesn't take an einstein to work out that a dendritic cell vaccine is going to prove safer than any highly toxic chemo treatment. Secondly if one wishes to truly compare or determine the efficacy between two seperate treatments, would one not be more enlightened if the trials were conducted on each treatment as the first-line therapy?

Crazy world we live in... or perhaps it's just me?